CVE-2022-48226 is a privilege escalation vulnerability in Acuant AcuFill SDK prior to version 10.22.02.03. During installation, a standard user can pre-create a specific executable path within C:\Windows\Temp, leading to elevated code execution. This vulnerability is rated as High severity (CVSS 7.8) due to its local attack vector, low complexity, and high impact on confidentiality, integrity, and availability. There is currently no evidence of active exploitation, public exploit code (Metasploit, Nuclei, ExploitDB), or significant community discussion or media coverage surrounding this CVE.
| Vendor | Product | Version(s) | CPE |
|---|---|---|---|
< 10.22.02.03CPE matchmatch criteria | cpe:2.3:a:gbgplc:acuant_acufill_sdk:*:*:*:*:*:*:*:* |
CVSS version used by this source: 3.1
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
The average CVE in this peer group has 0.0 Twitter, 0.1 Reddit, 0.2 Bluesky, 0.1 Mastodon, and 0.2 GitHub mentions.
No media coverage found for this CVE.
The average CVE in this peer group has 0.3 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.
Remediation records are not available for this CVE.